Search
cancer_statistics_and_incidence_rates.pdf
infographic.bp_goals_and_measurement_0.pdf
erbb_family_blockade_and_afatinib.pdf
tomato_and_carrot_soup.pdf
Caramelised_Figs_with_Rocket_and_Avocado.pdf
Respiratory Research and Development Timeline.pdf
honey_and_cinnamon_cookies_recipe.pdf
Blood Pressure Goals and Measurement.pdf
Unbranded illustrated factsheet.pdf
Telling my story AF and DVT PE Patient Voices
Breakthrough Designation granted in US and China
SPEVIGO® granted Breakthrough Therapy Designation in the U.S. for the prevention of generalized pustular psoriasis flares
Understanding heart failure
Heart failure is a complicated clinical condition which affects more than 60 million people worldwide. Find out more about the condition here.
Animal Health and Animal Welfare at Boehringer Ingelheim
Upstream and Downstream Processing | Bioxcellence | Boehringer Ingelheim
Experience our exceptional expertise in upstream & downstream biopharmaceutical processing, utilizing mammalian cell cultures & microbial organisms.
Harold_and_Dorothy_Patient_Discussion_Guide_Factsheet_0.pdf
Proven and trustworthy
Boehringer Ingelheim - Whitepaper High throughput cultivation platform microbial strain and process development
Blood Eosinophils and COPD
Partnering Vanderbilt WCNDD
Boehringer Ingelheim and the Warren Center for Neuroscience Drug Discovery are partnering to find new medicines for patients with neuropsychiatric disorders.
Alexander Kurz
Maria Isabel Rodriguez Fernandez
Cardiovascular renal and metabolic diseases infographic
Mental health: a $1 trillion burden demanding policy action
Nearly one billion people around the world live with a mental health condition, yet an estimated 70% don’t have access to the help they need.